Around 1–5% of all couples experience recurrent pregnancy loss (RPL). Established risk
factors include anatomical, genetic, endocrine, and hemostatic alterations. With around 50 …

STUDY QUESTION What is the recommended management of women with recurrent
pregnancy loss (RPL) based on the best available evidence in the literature? SUMMARY …

Infertility has been recognized as a civilizational disease. One of the most common causes
of infertility is polycystic ovary syndrome (PCOS). Closely interrelated immunometabolic …

Ziel Offizielle Leitlinie der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe
(DGGG), der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe (ÖGGG) und …

SUMMARY ANSWER: The guideline development group formulated 77 recommendations
answering 18 key questions on investigations and treatments for RPL, and on how care …

In the present manuscript, we review the recent research investigating the pathogenic
association between most studied autoantibodies and recurrent pregnancy loss. Pregnancy …

In the past decade, the incidence of recurrent pregnancy loss (RPL) has increased
significantly, and immunological disorders have been considered as one of the possible …

For over three decades researchers have pursued immunological causes and treatment for
recurrent pregnancy loss (RPL)(1). Despite these efforts immunological testing and …

Background Multiple etiologies contribute to recurrent pregnancy loss (RPL) including
immunological, endocrine, anatomical, genetic and infection but more than 50% of cases …

Background The role of autoantibodies in recurrent miscarriage (RM) is unclear. Commonly
studied autoimmune markers in RM include anti-nuclear (ANA), thyroid peroxidase (TPO …